High Dose Rifapentine Pharmacokinetics, Tolerability and Safety Dosage Rifapentine for Treatment of Tuberculosis
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to characterize rifapentine drug levels in patients
with TB in relationship to its effectiveness in treating TB and any adverse effects
experienced by participants.